⊙Role D, a broad-spectrum hyperlipidemia treatment drug, launched ⊙

 

 

 

Roeldi Tablet, a broad-spectrum hyperlipidemia treatment, was released on July 1, 2003.
Roeldi Tablets are effective in treating not only types Ⅱa and Ⅱb but also types Ⅲ and Ⅳ hyperlipidemia, and their efficacy has been proven in various patient groups, including significantly reducing the total mortality rate and coronary artery mortality rate in diabetic patients with myocardial infarction or angina pectoris.
Additionally, you can use it with confidence as it has been approved for bioequivalence testing.


● Ingredients and content
     simvastatin 20mg

● Efficacy.Effectiveness
1. Coronary artery disease: Reduces the risk of hypercholesterolemic patients with coronary artery disease
2.Hyperlipidemia: Primary hypercholesterolemia (heterogeneous familial and non-familial types) and mixed type
Elevated total cholesterol, LDL-cholesterol in patients with hyperlipidemia,
Dietary treatment to reduce apo-B protein and triglyceride levels
It is a supplement.
1) Type Ⅱa: Hypercholesterolemia
2) Type Ⅱb: Combined type of hypercholesterolemia and hypertriglyceridemia
3) Type Ⅲ: Primary dysbetalipoproteinemia
4) Type Ⅳ: Hypertriglyceridemia
Before starting treatment with this drug, it must be confirmed whether there is a cause of secondary hyperlipidemia, and total cholesterol
Measure lipid concentrations such as sterols, HDL-cholesterol, and triglycerides.

● Usage. Dosage
Patients before and while taking this drug must follow a standard cholesterol-lowering diet.
The initial starting dose is 20 mg once a day in the evening.
Start with 10 mg only if the goal is reduction. 5 to 80 mg once a day in the evening
Administer.
The initial LDL-cholesterol level before administration, the target value of treatment, and the patient's response to the drug
Increase or decrease the dose appropriately.
Adjust the dosage at intervals of 4 weeks or more.
Administration to patients with familial hypercholesterolemia: 40 mg per day in the evening or
A total of 80 mg per day is administered in 3 divided doses of 20 mg, 20 mg, and 40 mg in the evening.
              

● Insurance drug price: 1,251 won

● Insurance code: A17603771

● Packaging unit: 100T